Nirsevimab gets Promising Innovative Medicine Designation from MHRA
Nirsevimab is an innovative monoclonal antibody in Phase 2 and Phase 3 trials for the prevention of respiratory syncytial virus…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.